Spain – Various medicinal products – Suministro de los principios activos denominados "Mavacamten 15 MG ORAL", "Mavacamt
Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín awarded a contract of undisclosed value to BRISTOL-MYERS SQUIBB, S.A for Construction & Public Works in June 2025 — one of 265 awards this buyer has made.
Winning supplier
BRISTOL-MYERS SQUIBB, S.AContract description
Spain – Various medicinal products – Suministro de los principios activos denominados "Mavacamten 15 MG ORAL", "Mavacamten 5 MG ORAL", "Mavacamten 10 MG ORAL","Deucravacitinib 6MG" Y "Fedratinib 100 MG".
Related awards · Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
265 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-199904-2026ACJ, S.A.U.€698K23 Mar 2026 Construction
- ocds-ted-37645-2025PALEX MEDICAL, S.A.€666K20 Jan 2025 Construction
- ocds-ted-497865-2024GETINGE GROUP SPAIN, S.L.U.€583K20 Aug 2024 Professional Services
Other wins · BRISTOL-MYERS SQUIBB, S.A
65 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-431930-2026OSAKIDETZA - Servicio Vasco de Salud - Organización Central€64.7M25 Jun 2026 Construction
- ocds-ted-680665-2024OSAKIDETZA - Servicio Vasco de Salud - Organización Central€18.3M08 Nov 2024 Construction
- ocds-ted-435978-2026-6SERGAS. Servicio Gallego de Salud.€13.0M25 Jun 2026 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín and BRISTOL-MYERS SQUIBB, S.A — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back